| Merck (Schweiz) AG - Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze |
| 56364 | | 01 | | Ovitrelle 250 µg | | Injektionslösung in einer Fertigspritze | | G03GA08 | | Choriogonadotropin Alfa | | 17.02.2004 | | |
|
| Composition |
| choriogonadotropinum alfa 250 µg, poloxamerum 188, mannitolum, acidum phosphoricum concentratum, natrii hydroxidum corresp. natrium 0.1 mg, methioninum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Choriogonadotropin Alfa | 250µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Choriogonadotropin Alfa | 250 mcg |
| | | | Inactive agents | Dose |
|---|
| Acidum Phosphoricum Concentrate | | | Mannitol | | | Methionine | | | Sodium Hydroxide | | | Poloxamer | 188 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 007 | syringe(s) | 30.74 | 49.85 | A | SL | No |
|
